PT-2026-50821 · Apollo Pharmacy · Blood Glucose Monitoring System Apg-01

·

CVE-2026-50034

·

Published

2026-06-18

·

Updated

2026-06-22

CVSS v3.1

6.5

Medium

VectorAV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
Name of the Vulnerable Software and Affected Versions Apollo Pharmacy Blood Glucose Monitoring System APG-01 (affected versions not specified)
Description An attacker within Bluetooth Low Energy (BLE) communication range can passively intercept wireless traffic to obtain sensitive health-related information, such as glucose measurement values. BLE is a wireless personal area network technology designed for low power consumption.
Recommendations At the moment, there is no information about a newer version that contains a fix for this vulnerability.

Cleartext Transmission of Sensitive Information

Found an issue in the description? Have something to add? Feel free to write us 👾

Weakness Enumeration

Related Identifiers

CVE-2026-50034

Affected Products

Blood Glucose Monitoring System Apg-01